Pre-clinical evaluation of EC1456, a folate-tubulysin anti-cancer therapeutic

por Reddy, Joseph A., Dorton, Ryan, Bloomfield, Alicia, Nelson, Melissa, Dircksen, Christina, Vetzel, Marilynn, Kleindl, Paul, Santhapuram, Hari, Vlahov, Iontcho R., Leamon, Christopher P.
Publicado 2018

Preclinical Evaluation of Bispecific Adaptor Molecule Controlled Folate Receptor CAR-T Cell Therapy With Special Focus on Pediatric Malignancies

por Lu, Yingjuan J., Chu, Haiyan, Wheeler, Leroy W., Nelson, Melissa, Westrick, Elaine, Matthaei, James F., Cardle, Ian I., Johnson, Adam, Gustafson, Joshua, Parker, Nikki, Vetzel, Marilynn, Xu, Le-Cun, Wang, Emilia Z., Jensen, Michael C., Klein, Patrick J., Low, Philip S., Leamon, Christopher P.
Publicado 2019

Pre-clinical studies of EC2629, a highly potent folate- receptor-targeted DNA crosslinking agent

por Reddy, Joseph A., Nelson, Melissa, Dircksen, Christina, Vetzel, Marilynn, Johnson, Theresa, Cross, Vicky, Westrick, Elaine, Qi, LongWu, Hahn, Spencer, Santhapuram, Hari Krishna, Parham, Garth, Wang, Kevin, Vaughn, Jeremy F., Felten, Albert, Pugh, Michael, Lu, June, Klein, Patrick, Vlahov, Iontcho R., Leamon, Christopher P.
Publicado 2020